APOLLON: A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC).

Yasutoshi Kuboki,Takayuki Yoshino,Takeshi Kato,Kagawa Y,Makio Gamoh,Hirofumi Yasui,Kentaro Yamazaki,Yoshito Komatsu,Hironaga Satake,Masahiro Goto,Hiroaki Tanioka,Eiji Oki,Masahito Kotaka,Akitaka Makiyama,Tadamichi Denda,Junpei Soeda,Kazunori Shibuya,Masaru Iwata,Koji Oba,Kensei Yamaguchi

APOLLON: A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC).

2018

3523Background: APOLLON is an open-label, single-arm phase I/II study investigating the efficacy and safety of panitumumab (Pmab) in combination with TAS-102 (trifluridine/tipiracil) in pts with RA...

Keywords:

Pathology
Wild type
Colorectal cancer
Panitumumab
Cancer research
Medicine
Tipiracil
Trifluridine
Oncology
in patient
Internal medicine
phase i ii

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations